rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Abhinav Jain

Director

Company insider

Files Form 4 as: Director, Xtant Medical Holdings; Director, Aytu BioPharma; Director, Talphera.

In numbers

Trades disclosed
19
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
3
First trade
11 Aug 2023
Last trade
15 Aug 2026
Last filed
18 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
XTNT Xtant Medical HoldingsDirector · Medical Devices · last 15 Aug 20260 buys · 0 sells
AYTU Aytu BioPharmaDirector · Biotechnology · last 28 Jul 20260 buys · 0 sells
TLPH TalpheraDirector · Biotechnology · last 22 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Aug 2026filed 18 Aug 2026XTNT Xtant Medical HoldingsMedical DevicesSEC FORM 4 Code A—215,517 at $0.00filing
15 Aug 2026filed 18 Aug 2026XTNT Xtant Medical HoldingsMedical DevicesSEC FORM 4 Code A—215,517 at $0.00filing
28 Jul 2026filed 30 Jul 2026AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
28 Jul 2026filed 30 Jul 2026AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
22 Jun 2026filed 24 Jun 2026TLPH TalpheraBiotechnologySEC FORM 4 Code A—5,100 at $0.00filing
22 Jun 2026filed 24 Jun 2026TLPH Talpheraoption or derivative · BiotechnologySEC FORM 4 Code A—30,700 at $0.00filing
22 Jun 2026filed 24 Jun 2026TLPH Talpheraoption or derivative · BiotechnologySEC FORM 4 Code A—30,700 at $0.00filing
22 Jun 2026filed 24 Jun 2026TLPH TalpheraBiotechnologySEC FORM 4 Code A—5,100 at $0.00filing
15 Nov 2025filed 18 Nov 2025XTNT Xtant Medical HoldingsMedical DevicesSEC FORM 4 Code A—158,228 at $0.00filing
23 Oct 2025filed 24 Oct 2025TLPH Talpheraoption or derivative · BiotechnologySEC FORM 4 Code A—25,600 at $0.00filing
23 Oct 2025filed 24 Oct 2025TLPH TalpheraBiotechnologySEC FORM 4 Code A—4,267 at $0.00filing
3 Oct 2025filed 7 Oct 2025AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
6 Nov 2024filed 8 Nov 2024AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
24 Jun 2024filed 24 Jun 2024TLPH Talpheraoption or derivative · BiotechnologySEC FORM 4 Code A—13,044 at $0.00filing
24 Jun 2024filed 24 Jun 2024TLPH TalpheraBiotechnologySEC FORM 4 Code A—2,174 at $0.00filing
22 Jan 2024filed 23 Jan 2024TLPH Talpheraoption or derivative · BiotechnologySEC FORM 4 Code A—5,228 at $0.00filing
22 Jan 2024filed 23 Jan 2024TLPH TalpheraBiotechnologySEC FORM 4 Code A—871 at $0.00filing
16 Aug 2023filed 18 Aug 2023AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—6,500 at $0.00filing
11 Aug 2023filed 15 Aug 2023AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—1,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Stavros G. VizirgianakisDirector · Director at Xtant Medical Holdings, filing Form 4 there in the last year
Tyler LipschultzDirector · Director at Xtant Medical Holdings, filing Form 4 there in the last year
Mark A. SchallenbergerChief Operating Officer · Chief Operating Officer at Xtant Medical Holdings, filing Form 4 there in the last year
Jonn R. BeesonDirector · Director at Xtant Medical Holdings, filing Form 4 there in the last year
Scott C. NeilsCFO and Assistant Secretary · CFO and Assistant Secretary at Xtant Medical Holdings, filing Form 4 there in the last year